David Freundlich, Vice President of Clinical R&D, oversees a variety of programs to develop the capabilities of InSightec’s Magnetic Resonance guided Focused Ultrasound technology, marketed as ExAblate 2000 and to educate and familiarize physicians with its use.
Prior to joining InSightec in 1999, Dr. Freundlich served as Vice President of Marketing for Elbit Medical. Previously Dr. Freundlich spent twenty three years at Elscint Ltd, where he held various positions including CT R&D Manager, MRI R&D Manager, Corporate CT Chief Scientist and Vice President of Marketing. He also was awarded the 1980 Rotshiled Award for Industrial Developments.
Dr. Freundlich received his Ph.D in Nuclear Physics from The Hebrew University in Jerusalem. He also holds a M.Sc. in Physics and a BSc. in Physics & Mathematics from the same institution.
